Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase

Protein interactions of the Amyotrophic Lateral Sclerosis (ALS)-linked copper–zinc superoxide dismutase (hSOD1) G93A mutation were studied using a fluorescence resonance energy transfer (FRET) based screening system. The FRET results confirmed by pull-down immunoprecipitation indicated “gain-of-inte...

Full description

Bibliographic Details
Main Authors: Yael Mali, Nava Zisapels
Format: Article
Language:English
Published: Elsevier 2008-10-01
Series:Neurobiology of Disease
Subjects:
ALS
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996108001423
id doaj-c6d8ff9843dc4baf8d374b0923b337c3
record_format Article
spelling doaj-c6d8ff9843dc4baf8d374b0923b337c32021-03-20T04:56:07ZengElsevierNeurobiology of Disease1095-953X2008-10-01321133141Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenaseYael Mali0Nava Zisapels1Department of Neurobiology, Tel Aviv University, Tel Aviv 69978, IsraelCorresponding author. Fax: +972 3 6407643.; Department of Neurobiology, Tel Aviv University, Tel Aviv 69978, IsraelProtein interactions of the Amyotrophic Lateral Sclerosis (ALS)-linked copper–zinc superoxide dismutase (hSOD1) G93A mutation were studied using a fluorescence resonance energy transfer (FRET) based screening system. The FRET results confirmed by pull-down immunoprecipitation indicated “gain-of-interaction” of the G93A-hSOD1 mutant with cytosolic malate dehydrogenase (cytMDH)—a key enzyme in the malate–aspartate shuttle which is vital to neurons. Furthermore, cytMDH mRNA expression was upregulated in G93A-hSOD1 expressing cells but endogenous cytMDH enzymatic activity was not enhanced, not even with exogenously added-on enzyme. Consistent with inhibition of the malate–aspartate shuttle, G93A-hSOD1 had lower malate and higher lactate levels compared to non-induced or Wild-Type-hSOD1 expressing cells. Mitochondrial NADH/NAD+ ratio is also elevated. Malate–aspartate shuttle dysfunction may explain the damage to neurons and the vulnerability to impairments of glycolytic pathways in ALS and provide a new target for the development of potential therapies.http://www.sciencedirect.com/science/article/pii/S0969996108001423SOD1ALSAmyotrophic Lateral SclerosisMalate dehydrogenaseProtein interactionsFRET
collection DOAJ
language English
format Article
sources DOAJ
author Yael Mali
Nava Zisapels
spellingShingle Yael Mali
Nava Zisapels
Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase
Neurobiology of Disease
SOD1
ALS
Amyotrophic Lateral Sclerosis
Malate dehydrogenase
Protein interactions
FRET
author_facet Yael Mali
Nava Zisapels
author_sort Yael Mali
title Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase
title_short Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase
title_full Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase
title_fullStr Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase
title_full_unstemmed Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase
title_sort gain of interaction of als-linked g93a superoxide dismutase with cytosolic malate dehydrogenase
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2008-10-01
description Protein interactions of the Amyotrophic Lateral Sclerosis (ALS)-linked copper–zinc superoxide dismutase (hSOD1) G93A mutation were studied using a fluorescence resonance energy transfer (FRET) based screening system. The FRET results confirmed by pull-down immunoprecipitation indicated “gain-of-interaction” of the G93A-hSOD1 mutant with cytosolic malate dehydrogenase (cytMDH)—a key enzyme in the malate–aspartate shuttle which is vital to neurons. Furthermore, cytMDH mRNA expression was upregulated in G93A-hSOD1 expressing cells but endogenous cytMDH enzymatic activity was not enhanced, not even with exogenously added-on enzyme. Consistent with inhibition of the malate–aspartate shuttle, G93A-hSOD1 had lower malate and higher lactate levels compared to non-induced or Wild-Type-hSOD1 expressing cells. Mitochondrial NADH/NAD+ ratio is also elevated. Malate–aspartate shuttle dysfunction may explain the damage to neurons and the vulnerability to impairments of glycolytic pathways in ALS and provide a new target for the development of potential therapies.
topic SOD1
ALS
Amyotrophic Lateral Sclerosis
Malate dehydrogenase
Protein interactions
FRET
url http://www.sciencedirect.com/science/article/pii/S0969996108001423
work_keys_str_mv AT yaelmali gainofinteractionofalslinkedg93asuperoxidedismutasewithcytosolicmalatedehydrogenase
AT navazisapels gainofinteractionofalslinkedg93asuperoxidedismutasewithcytosolicmalatedehydrogenase
_version_ 1724211737705578496